FDA Adverse Event Injury Summary report: N

GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 4 L

MDR report key: 12133386 · Received July 8, 2021

Report

Report Number
3005180920-2021-00568
Event Type
Injury
Date Received
July 8, 2021
Date of Event
June 15, 2021
Report Date
July 8, 2021
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JWH
UDI-DI
07630030825835
PMA / PMN Number
K121416
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON 24.JUNE.2021: LOT 156273: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 26-01-2016. EXPIRATION DATE: 2021-01-06. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE,ALL ITEMS OF THIS SAME LOT HAVE BEEN SOLD WITHOUT OTHER SIMILAR REPORTED EVENTS SINCE 2017. ADDITIONAL IMPLANT INVOLVED: GMK-SPHERE 02.12.T3I4L TIBIAL TRAY FIXED CEMENTED SIZE T3-I4 L (K121416) LOT. 152006. BATCH REVIEW PERFORMED ON 24.JUNE.2021: LOT 152006: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 12-05-2015. EXPIRATION DATE: 2020-03-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THIS SAME LOT HAVE BEEN SOLD WITHOUT OTHER SIMILAR REPORTED EVENTS SINCE 2017. ADDITIONAL IMPLANT INVOLVED: GMK-SPHERE 02.12.0410FL TIBIAL INSERT FIXED SPHERE FLEX SIZE 4/10 MM L (K121416) LOT. 156095. BATCH REVIEW PERFORMED ON 24.JUNE.2021: LOT 156095: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 29-02-2015. EXPIRATION DATE: 2021-02-01. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THIS SAME LOT HAVE BEEN SOLD WITHOUT OTHER SIMILAR REPORTED EVENTS SINCE 2017.

Description of Event or Problem · 1

REVISION SURGERY PERFORMED ABOUT 5 YEARS AFTER THE PRIMARY SURGERY DUE TO LOW-GRADE INFECTION. ALL IMPLANTS WERE REVISED. THE EXACT PRIMARY DATE IS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1030131 GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 4 L CEMENTED FEMORAL COMPONENT JWH MEDACTA INTERNATIONAL SA 02.12.0004L 156273 07630030825835

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention